Lovaza and Dementia - a phase IV clinical study of FDA data

Summary:

Dementia is reported as a side effect among people who take Lovaza (omega-3-acid ethyl esters), especially for people who are male, 60+ old, have been taking the drug for 10+ years also take Aspirin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Dementia when taking Lovaza. It is created by eHealthMe based on reports of 16,646 people who have side effects when taking Lovaza from the FDA, and is updated regularly.

What is Lovaza?

Lovaza has active ingredients of omega-3-acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 17,340 Lovaza users. Check the latest studies of Lovaza.

What is Dementia?

Dementia (madness) is found to be associated with 1,206 drugs and 1,808 conditions by eHealthMe. Check the latest studies of Dementia.

On Jul, 29, 2026

16,646 people reported to have side effects when taking Lovaza.
Among them, 53 people (0.32%) have Dementia.

Among these 53 people:

How long have people been on Lovaza when they have Dementia? *

What is the gender of people who have Dementia when taking Lovaza? *

female: 26.42 %
male: 73.58 %

What is the age of people who have Dementia when taking Lovaza? *

What are other drugs people take besides Lovaza? *

What are other side effects people have besides Dementia? *

Osteonecrosis Of Jaw (death of bone of jaw): 30 people, 56.60%
Stress And Anxiety: 28 people, 52.83%
Pain: 28 people, 52.83%
Atelectasis (partial or complete collapse of the lung): 28 people, 52.83%
High Blood Pressure: 26 people, 49.06%
Pneumonia: 26 people, 49.06%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 26 people, 49.06%
Urinary Tract Infection: 25 people, 47.17%
Memory Loss: 25 people, 47.17%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 24 people, 45.28%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 15 people, 28.30%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 13.21%
Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 6 people, 11.32%
Metastases To Bone (cancer spreads to bone): 4 people, 7.55%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 5.66%
Osteoporosis (bones weak and more likely to break): 3 people, 5.66%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 5.66%
Oedema Peripheral (superficial swelling): 2 people, 3.77%
Renal Disorder (kidney disease): 2 people, 3.77%
Breast Cancer: 2 people, 3.77%

* Approximation only. Some reports may have incomplete information.

Do you take Lovaza and have Dementia?

- Check whether Dementia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lovaza:

Lovaza (17,340 reports)

Dementia treatments and more:

Dementia (44,271 reports)

Browse all side effects of Lovaza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dementia:

Dementia (1,206 drugs)

Browse all the conditions that are associated with Dementia:

Dementia (1,808 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omega-3-acid ethyl esters (the active ingredients of Lovaza) and Lovaza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.